CBD's Place in Delaware's Medical Marijuana Program: Insights and Obstacles
Delaware is one of the few US states that has a comprehensive medical marijuana program in place. It allows patients with qualifying conditions to access cannabis products, including those containing CBD (cannabidiol). CBD has become increasingly popular in recent years for its potential therapeutic benefits, but its place in Delaware's medical marijuana program is still far from certain. In this article, we'll explore what we know about CBD's place in Delaware's medical marijuana program, what the obstacles are to incorporating it more fully, and what you need to know as a patient.
What is CBD and Why is it Popular?
CBD is one of the many cannabinoids found in the cannabis plant. It does not produce the “high” associated with THC (tetrahydrocannabinol), another well-known cannabinoid. Instead, CBD has been shown to have potential therapeutic benefits for a range of conditions, including:
CBD is typically consumed in the form of an oil, capsule, or topical cream. It is legal in most US states as long as it is derived from hemp (a variety of cannabis with low levels of THC) and contains less than 0.3% THC.
What is Delaware’s Medical Marijuana Program?
Delaware's medical marijuana program was established in 2011. It allows patients with qualifying conditions (including cancer, HIV/AIDS, Parkinson's disease, and multiple sclerosis, among others) to access medical marijuana products. Patients must have a recommendation from a certified physician and obtain a medical marijuana card from the state in order to participate in the program.
In Delaware, medical marijuana products are available in several forms, including:
- Flower (the dried, smokable part of the plant)
- CBD oil and other cannabis oil products
- Topicals (creams, lotions, balms, etc.)
However, the availability and use of CBD products within the program is more limited than some patients may expect.
What is the Current Status of CBD in Delaware’s Medical Marijuana Program?
CBD is technically legal for medical use in Delaware, but it is subject to a number of restrictions within the medical marijuana program. Specifically, Delaware's medical marijuana law states that “cannabidiol-rich oil” (CBD oil) may only be dispensed to patients with “intractable epilepsy” who have not responded to other treatments. The law does not allow for the use of CBD for other medical conditions, even though there is substantial evidence that it may benefit patients with a range of issues.
This limitation on CBD is frustrating for many patients who are interested in trying it as a treatment option. However, there are efforts underway to change the law and expand the use of CBD within the medical marijuana program.
What are Some of the Obstacles to Expanding CBD Access in Delaware?
There are several factors that are contributing to the slow progress of incorporating CBD into Delaware's medical marijuana program:
- Federal Regulations: While many US states have legalized medical marijuana, the federal government still classifies cannabis as a Schedule I drug (meaning it is considered to have no medical benefit and a high potential for abuse). This creates legal complications for states that want to expand access to cannabis products that are not explicitly allowed under federal law, like CBD.
- Physician Education: Many physicians are still unfamiliar with the uses and benefits of CBD, and may be hesitant to recommend it to patients. This lack of education and awareness can be a barrier to expanding CBD access.
- Drug Testing: Some patients may be concerned about using CBD products because they fear it will trigger a positive drug test. While CBD is not psychoactive like THC, it can still show up on drug tests. However, there are now many CBD products available that are THC-free, which can alleviate this concern.
What Should Patients Know About CBD in Delaware’s Medical Marijuana Program?
- Under current regulations, CBD is only available to patients with intractable epilepsy who have not responded to other treatments. This may change in the future, but for now, patients with other conditions may need to look for CBD products outside of the medical marijuana program.
- Be sure to talk to your physician about CBD and any other treatment options you are considering. Your doctor can help you weigh the potential benefits and risks of using CBD and make an informed decision.
- Look for CBD products that are third-party tested and labeled accurately. Because CBD products are not regulated by the FDA, it can be difficult to know exactly what you are getting. Choosing products that have been independently tested can give you more confidence in their quality and safety.
CBD and Delaware’s Medical Marijuana Program: Conclusion
CBD has the potential to be a valuable treatment option for many patients with a range of conditions, but its place within Delaware's medical marijuana program is still uncertain. While there are many obstacles to expanding access to CBD, there are also efforts underway to change the law and increase physician education and awareness. For now, patients who are interested in CBD will need to explore their options outside of the medical marijuana program, but there is hope for a more inclusive approach in the future.
1. What is CBD?
CBD (cannabidiol) is a cannabinoid found in the cannabis plant. It is non-psychoactive and has potential therapeutic benefits for a range of conditions, including chronic pain, anxiety, and epilepsy.
2. Is CBD legal in Delaware?
CBD is legal in Delaware for medical use, but it is subject to a number of restrictions within the medical marijuana program. Specifically, it may only be dispensed to patients with intractable epilepsy who have not responded to other treatments.
3. What are some of the obstacles to expanding CBD access in Delaware?
Some of the factors that are contributing to slow progress in expanding CBD access in Delaware include federal regulations, physician education, and concerns about drug testing.
4. What should patients know about using CBD in Delaware's medical marijuana program?
Currently, CBD is only available to patients with intractable epilepsy who have not responded to other treatments. Patients with other conditions may need to explore their options outside of the medical marijuana program. It's important to talk to your doctor about any treatment options you are considering, and to look for third-party tested and labeled CBD products.